LeMaitre Vascular PE Ratio 2010-2024 | LMAT
Current and historical p/e ratio for LeMaitre Vascular (LMAT) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. LeMaitre Vascular PE ratio as of May 13, 2025 is 42.06.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| LeMaitre Vascular PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-05-13 | 83.28 | 42.93 | |
| 2024-12-31 | 91.91 | $1.94 | 47.38 |
| 2024-09-30 | 92.52 | $1.83 | 50.56 |
| 2024-06-30 | 81.79 | $1.67 | 48.98 |
| 2024-03-31 | 65.83 | $1.51 | 43.60 |
| 2023-12-31 | 56.17 | $1.34 | 41.92 |
| 2023-09-30 | 53.77 | $1.21 | 44.44 |
| 2023-06-30 | 66.24 | $1.13 | 58.62 |
| 2023-03-31 | 50.56 | $0.93 | 54.37 |
| 2022-12-31 | 45.08 | $0.93 | 48.47 |
| 2022-09-30 | 49.51 | $0.96 | 51.58 |
| 2022-06-30 | 44.39 | $1.01 | 43.95 |
| 2022-03-31 | 45.16 | $1.25 | 36.13 |
| 2021-12-31 | 48.69 | $1.26 | 38.64 |
| 2021-09-30 | 51.35 | $1.32 | 38.90 |
| 2021-06-30 | 58.90 | $1.39 | 42.38 |
| 2021-03-31 | 46.98 | $1.16 | 40.50 |
| 2020-12-31 | 38.92 | $1.04 | 37.42 |
| 2020-09-30 | 31.18 | $0.93 | 33.53 |
| 2020-06-30 | 25.23 | $0.81 | 31.14 |
| 2020-03-31 | 23.72 | $0.87 | 27.27 |
| 2019-12-31 | 34.11 | $0.88 | 38.76 |
| 2019-09-30 | 32.35 | $0.95 | 34.05 |
| 2019-06-30 | 26.41 | $0.91 | 29.02 |
| 2019-03-31 | 29.17 | $1.11 | 26.28 |
| 2018-12-31 | 22.18 | $1.13 | 19.63 |
| 2018-09-30 | 36.26 | $1.04 | 34.87 |
| 2018-06-30 | 31.28 | $1.08 | 28.96 |
| 2018-03-31 | 33.78 | $0.88 | 38.38 |
| 2017-12-31 | 29.63 | $0.85 | 34.86 |
| 2017-09-30 | 34.77 | $0.77 | 45.15 |
| 2017-06-30 | 28.96 | $0.69 | 41.97 |
| 2017-03-31 | 22.80 | $0.60 | 38.01 |
| 2016-12-31 | 23.41 | $0.55 | 42.56 |
| 2016-09-30 | 18.29 | $0.55 | 33.26 |
| 2016-06-30 | 13.12 | $0.49 | 26.78 |
| 2016-03-31 | 14.23 | $0.45 | 31.62 |
| 2015-12-31 | 15.77 | $0.42 | 37.54 |
| 2015-09-30 | 11.11 | $0.40 | 27.78 |
| 2015-06-30 | 10.96 | $0.34 | 32.24 |
| 2015-03-31 | 7.59 | $0.32 | 23.71 |
| 2014-12-31 | 6.89 | $0.23 | 29.96 |
| 2014-09-30 | 6.17 | $0.17 | 36.27 |
| 2014-06-30 | 7.38 | $0.17 | 43.40 |
| 2014-03-31 | 7.17 | $0.15 | 47.79 |
| 2013-12-31 | 7.08 | $0.21 | 33.73 |
| 2013-09-30 | 5.90 | $0.20 | 29.52 |
| 2013-06-30 | 5.74 | $0.19 | 30.20 |
| 2013-03-31 | 5.41 | $0.18 | 30.08 |
| 2012-12-31 | 4.99 | $0.15 | 33.25 |
| 2012-09-30 | 5.56 | $0.13 | 42.74 |
| 2012-06-30 | 5.17 | $0.17 | 30.43 |
| 2012-03-31 | 5.05 | $0.15 | 33.70 |
| 2011-12-31 | 5.06 | $0.13 | 38.90 |
| 2011-09-30 | 5.29 | $0.24 | 22.06 |
| 2011-06-30 | 6.00 | $0.25 | 24.00 |
| 2011-03-31 | 5.76 | $0.31 | 18.59 |
| 2010-12-31 | 5.71 | $0.37 | 15.44 |
| 2010-09-30 | 5.95 | $0.32 | 18.59 |
| 2010-06-30 | 4.72 | $0.31 | 15.24 |
| 2010-03-31 | 3.80 | $0.28 | 13.56 |
| 2009-12-31 | 4.22 | $0.10 | 42.19 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.882B | $0.220B |
| LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $224.526B | 27.00 |
| Boston Scientific (BSX) | United States | $152.309B | 38.13 |
| Stryker (SYK) | United States | $147.916B | 30.93 |
| EssilorLuxottica (ESLOY) | France | $129.703B | 0.00 |
| Medtronic (MDT) | Ireland | $109.157B | 15.94 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.583B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.109B | 26.80 |
| ResMed (RMD) | United States | $36.312B | 27.27 |
| GE HealthCare Technologies (GEHC) | United States | $33.806B | 16.05 |
| Agilent Technologies (A) | United States | $32.907B | 21.74 |
| Terumo (TRUMY) | Japan | $27.953B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.765B | 16.36 |
| Insulet (PODD) | United States | $22.130B | 86.87 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.288B | 12.39 |
| Baxter (BAX) | United States | $15.985B | 11.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.381B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.091B | 23.97 |
| Lantheus Holdings (LNTH) | United States | $5.462B | 13.78 |
| Prestige Consumer Healthcare (PBH) | United States | $4.298B | 19.20 |
| Perrigo (PRGO) | Ireland | $3.605B | 9.14 |
| ICU Medical (ICUI) | United States | $3.534B | 26.06 |
| Haemonetics (HAE) | United States | $3.473B | 15.13 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.154B | 26.21 |
| QuidelOrtho (QDEL) | United States | $2.401B | 16.52 |
| GN Store Nord (GNNDY) | Denmark | $2.164B | 17.92 |
| AtriCure (ATRC) | United States | $1.558B | 0.00 |
| Neogen (NEOG) | United States | $1.409B | 18.03 |
| AdaptHealth (AHCO) | United States | $1.217B | 12.36 |
| Kestra Medical Technologies (KMTS) | United States | $1.179B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.172B | 26.35 |
| BioLife Solutions (BLFS) | United States | $1.097B | 0.00 |
| InMode (INMD) | Israel | $1.038B | 9.50 |
| Phibro Animal Health (PAHC) | United States | $0.996B | 12.75 |
| Evolus (EOLS) | United States | $0.653B | 0.00 |
| CeriBell (CBLL) | United States | $0.600B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.577B | 0.00 |
| Owens & Minor (OMI) | United States | $0.559B | 4.63 |
| Valneva SE (VALN) | France | $0.534B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.524B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.453B | 0.00 |
| Surmodics (SRDX) | United States | $0.398B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.350B | 0.00 |
| SNDL (SNDL) | Canada | $0.347B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.333B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.312B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.309B | 11.36 |
| Aurora Cannabis (ACB) | Canada | $0.290B | 51.60 |
| Sanuwave Health (SNWV) | United States | $0.285B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.97 |
| Canopy Growth (CGC) | Canada | $0.267B | 0.00 |
| Omeros (OMER) | United States | $0.258B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.255B | 0.00 |
| Cerus (CERS) | United States | $0.250B | 0.00 |
| ZimVie (ZIMV) | United States | $0.248B | 11.28 |
| Biote (BTMD) | United States | $0.214B | 6.02 |
| OraSure Technologies (OSUR) | United States | $0.198B | 0.00 |
| High Tide (HITI) | Canada | $0.186B | 0.00 |
| Brainsway (BWAY) | Israel | $0.185B | 49.05 |
| Quanterix (QTRX) | United States | $0.180B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 14.47 |
| Organigram Global (OGI) | Canada | $0.166B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.164B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.148B | 18.19 |
| Jin Medical (ZJYL) | China | $0.133B | 0.00 |
| Exagen (XGN) | United States | $0.120B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.116B | 0.00 |
| Agape ATP (ATPC) | $0.101B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Fonar (FONR) | United States | $0.077B | 10.71 |
| Veru (VERU) | United States | $0.076B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.070B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.070B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| United Health Products (UEEC) | United States | $0.061B | 0.00 |
| Apyx Medical (APYX) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Safety Shot (SHOT) | United States | $0.034B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.020B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |